Ibnsina Pharma (EGX:ISPH)
Egypt
· Delayed Price · Currency is EGP 8.87
0.00 (0.00%)
At close: Mar 27, 2025
Ibnsina Pharma Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 614.56 | 213.66 | 172.58 | 314.73 | 224.66 | Upgrade
|
| Depreciation & Amortization | 242.2 | 184.22 | 182.53 | 175.34 | 129.21 | Upgrade
|
| Other Amortization | 23.53 | 6.57 | 5.64 | 2.75 | 1.91 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.95 | -1.39 | -1.21 | -4.25 | -1.94 | Upgrade
|
| Loss (Gain) on Equity Investments | -1.56 | 1.13 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 215.37 | 83.85 | 65.53 | -45.13 | 24.34 | Upgrade
|
| Other Operating Activities | 407.75 | 173.02 | -41.75 | 88.58 | -13.32 | Upgrade
|
| Change in Accounts Receivable | -6,643 | -4,068 | -85.2 | -1,284 | -410.14 | Upgrade
|
| Change in Inventory | -3,578 | -671.73 | -400.14 | -194.15 | -348.14 | Upgrade
|
| Change in Accounts Payable | 8,151 | 4,386 | 558.68 | 697.3 | 751.2 | Upgrade
|
| Change in Other Net Operating Assets | -356.43 | -181.75 | -94.79 | -91.78 | -105.91 | Upgrade
|
| Operating Cash Flow | -926.58 | 125.81 | 361.88 | -340.43 | 251.87 | Upgrade
|
| Operating Cash Flow Growth | - | -65.23% | - | - | - | Upgrade
|
| Capital Expenditures | -258.07 | -354.04 | -798.46 | -147.53 | -230.13 | Upgrade
|
| Sale of Property, Plant & Equipment | 23.4 | 82.45 | 50.45 | 16.01 | 2.42 | Upgrade
|
| Sale (Purchase) of Intangibles | -22.89 | -8.23 | -26.18 | -11.15 | -0.32 | Upgrade
|
| Other Investing Activities | -1.98 | - | -601.86 | - | - | Upgrade
|
| Investing Cash Flow | -259.54 | -279.82 | -1,376 | -142.67 | -228.03 | Upgrade
|
| Short-Term Debt Issued | 1,214 | 875.52 | 721.63 | 960.4 | 330.99 | Upgrade
|
| Long-Term Debt Issued | 577.29 | 362.57 | 712.39 | - | - | Upgrade
|
| Total Debt Issued | 1,791 | 1,238 | 1,434 | 960.4 | 330.99 | Upgrade
|
| Long-Term Debt Repaid | -874.29 | -471.63 | -21.53 | -250.65 | -120.39 | Upgrade
|
| Total Debt Repaid | -874.29 | -471.63 | -21.53 | -250.65 | -120.39 | Upgrade
|
| Net Debt Issued (Repaid) | 916.87 | 766.46 | 1,412 | 709.75 | 210.6 | Upgrade
|
| Issuance of Common Stock | - | - | 0.49 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -185.74 | -14.4 | - | Upgrade
|
| Common Dividends Paid | -25.62 | -22.94 | -140.4 | -14.59 | -82.02 | Upgrade
|
| Financing Cash Flow | 891.25 | 743.52 | 1,087 | 680.77 | 128.58 | Upgrade
|
| Net Cash Flow | -294.87 | 589.52 | 72.67 | 197.66 | 152.42 | Upgrade
|
| Free Cash Flow | -1,185 | -228.23 | -436.58 | -487.96 | 21.75 | Upgrade
|
| Free Cash Flow Margin | -2.12% | -0.67% | -1.96% | -2.25% | 0.12% | Upgrade
|
| Free Cash Flow Per Share | -1.18 | -0.23 | -0.43 | -0.38 | 0.02 | Upgrade
|
| Cash Interest Paid | 1,375 | 929.98 | 481.52 | 281.54 | 250.34 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 76.32 | 85.85 | Upgrade
|
| Levered Free Cash Flow | -7,042 | -2,724 | -1,495 | -617.13 | -1,068 | Upgrade
|
| Unlevered Free Cash Flow | -5,988 | -2,071 | -1,197 | -439.52 | -908.37 | Upgrade
|
| Change in Net Working Capital | 7,384 | 2,620 | 861.91 | 876.02 | 1,114 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.